Nikhil C. Munshi

Nikhil C. Munshi is a Professor of Medicine at Harvard Medical School and holds multiple leadership roles at Dana-Farber Cancer Institute, including Director of Basic and Correlative Science at the Jerome Lipper Multiple Myeloma Center, Director of Multiple Myeloma Immune Effector Cell Therapy, and Kraft Family Chair. He specializes in medical oncology, focusing on multiple myeloma and CAR T-cell therapy.

Education:

• MD from Maharaja Sayjirao University, India (1984)
• Postgraduate training in Internal Medicine at SSG Hospital and Maharaja Sayjirao University
• Fellowships in Hematology/Oncology at Johns Hopkins Oncology Center and Indiana University Medical Center

Research Interests: Dr. Munshi’s work centers on understanding and treating multiple myeloma, advancing immune effector cell therapies (e.g., CAR T-cells), and improving outcomes through correlative science. His contributions have positioned him as a leader in hematologic oncology.

Awards & Recognition: Recurrently listed among the world’s most highly cited researchers in cancer research (2022–2024).

Labs/Teams: Leads the Jerome Lipper Multiple Myeloma Center and directs the Multiple Myeloma Immune Effector Cell Therapy program at Dana-Farber, collaborating on translational and clinical research initiatives.